Nombre   Subyacente Vencimiento Precio de ejercicio Cap Descuento % Rendimiento máximo por año %  
Morgan Stanley Discount Zert NVO 27.06.2025   Novo Nordisk 27/06/2025 - 100.00 21.15% 11.21%
Morgan Stanley Discount Zert NVO 27.06.2025   Novo Nordisk 27/06/2025 - 80.00 34.90% 6.47%
Morgan Stanley Discount Zert NVO 27.06.2025   Novo Nordisk 27/06/2025 - 120.00 10.84% 20.57%
Morgan Stanley Discount Zert NVO 31.12.2024   Novo Nordisk 31/12/2024 - 150.00 0.16% -
Morgan Stanley Discount Zert NVO 28.03.2025   Novo Nordisk 28/03/2025 - 160.00 0.68% 81.86%
Morgan Stanley Discount Zert NVO 25.06.2026   Novo Nordisk 25/06/2026 - 150.00 9.08% 23.55%
Morgan Stanley Discount Zert NVO 25.06.2026   Novo Nordisk 25/06/2026 - 110.00 22.25% 11.89%
Morgan Stanley Discount Zert NVO 30.12.2025   Novo Nordisk 30/12/2025 - 150.00 6.10% 29.38%
Morgan Stanley Discount Zert NVO 28.03.2025   Novo Nordisk 28/03/2025 - 70.00 41.76% 5.02%
Morgan Stanley Discount Zert NVO 27.06.2025   Novo Nordisk 27/06/2025 - 140.00 4.76% 35.54%
Morgan Stanley Discount Zert NVO 31.12.2024   Novo Nordisk 31/12/2024 - 80.00 32.66% -
Morgan Stanley Discount Zert NVO 31.12.2024   Novo Nordisk 31/12/2024 - 110.00 10.51% -
Morgan Stanley Discount Zert NVO 31.12.2024   Novo Nordisk 31/12/2024 - 70.00 40.96% -
Morgan Stanley Discount Zert NVO 28.03.2025   Novo Nordisk 28/03/2025 - 110.00 13.28% 17.51%
Morgan Stanley Discount Zert NVO 30.12.2025   Novo Nordisk 30/12/2025 - 70.00 44.22% 5.54%
Morgan Stanley Discount Zert NVO 30.12.2025   Novo Nordisk 30/12/2025 - 110.00 19.20% 12.95%
Morgan Stanley Discount Zert NVO 25.06.2026   Novo Nordisk 25/06/2026 - 130.00 14.38% 17.03%
Morgan Stanley Discount Zert NVO 25.06.2026   Novo Nordisk 25/06/2026 - 160.00 7.16% 27.21%
Morgan Stanley Discount Zert NVO 30.12.2025   Novo Nordisk 30/12/2025 - 130.00 11.15% 20.04%
Morgan Stanley Discount Zert NVO 30.12.2025   Novo Nordisk 30/12/2025 - 90.00 30.44% 8.25%
Morgan Stanley Discount Zert NVO 27.06.2025   Novo Nordisk 27/06/2025 - 150.00 3.05% 44.84%
Morgan Stanley Discount Zert NVO 31.12.2024   Novo Nordisk 31/12/2024 - 130.00 2.47% -